Protein S deficiency: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 32: Line 32:


===Genetics===
===Genetics===
Hereditary PSD is an [[autosomal dominant]] condition, resulting in a 50 percent chance of passing the disease to offspring. Less than half of those diagnosed with PSD will experience [[thrombosis]], and those who do usually are affected only from the age of the late teens onwards. A positive [[blood test]] can lead to the loss of [[health insurance]] benefits and/or employment, and the social downsides need to be balanced against the actual medical benefit of accurate diagnosis. Screening of young children is usually deferred because early testing is often inaccurate, and it is better to wait until they are old enough to decide for themselves whether they want to be tested.
Hereditary PSD is an [[autosomal dominant]] condition, resulting in a 50 percent chance of passing the disease to offspring. Less than half of those diagnosed with PSD will experience [[thrombosis]], and those who do usually are affected only from the age of the late teens onwards.
 
==Cost-Effectiveness of Therapy==
A positive [[blood test]] can lead to the loss of [[health insurance]] benefits and/or employment, and the social downsides need to be balanced against the actual medical benefit of accurate diagnosis. Screening of young children is usually deferred because early testing is often inaccurate, and it is better to wait until they are old enough to decide for themselves whether they want to be tested.


==References==
==References==

Revision as of 13:37, 21 September 2012

Protein S deficiency
ICD-9 289.81
OMIM 176880
DiseasesDB 10814
MedlinePlus 000559
MeSH D018455

WikiDoc Resources for Protein S deficiency

Articles

Most recent articles on Protein S deficiency

Most cited articles on Protein S deficiency

Review articles on Protein S deficiency

Articles on Protein S deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Protein S deficiency

Images of Protein S deficiency

Photos of Protein S deficiency

Podcasts & MP3s on Protein S deficiency

Videos on Protein S deficiency

Evidence Based Medicine

Cochrane Collaboration on Protein S deficiency

Bandolier on Protein S deficiency

TRIP on Protein S deficiency

Clinical Trials

Ongoing Trials on Protein S deficiency at Clinical Trials.gov

Trial results on Protein S deficiency

Clinical Trials on Protein S deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Protein S deficiency

NICE Guidance on Protein S deficiency

NHS PRODIGY Guidance

FDA on Protein S deficiency

CDC on Protein S deficiency

Books

Books on Protein S deficiency

News

Protein S deficiency in the news

Be alerted to news on Protein S deficiency

News trends on Protein S deficiency

Commentary

Blogs on Protein S deficiency

Definitions

Definitions of Protein S deficiency

Patient Resources / Community

Patient resources on Protein S deficiency

Discussion groups on Protein S deficiency

Patient Handouts on Protein S deficiency

Directions to Hospitals Treating Protein S deficiency

Risk calculators and risk factors for Protein S deficiency

Healthcare Provider Resources

Symptoms of Protein S deficiency

Causes & Risk Factors for Protein S deficiency

Diagnostic studies for Protein S deficiency

Treatment of Protein S deficiency

Continuing Medical Education (CME)

CME Programs on Protein S deficiency

International

Protein S deficiency en Espanol

Protein S deficiency en Francais

Business

Protein S deficiency in the Marketplace

Patents on Protein S deficiency

Experimental / Informatics

List of terms related to Protein S deficiency

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Protein S deficiency is a disorder associated with increased risk of venous thrombosis. Protein S, a vitamin K-dependent physiological anticoagulant, acts as a nonenzymatic cofactor to activated protein C in the proteolytic degradation of factor Va and factor VIIIa. Decreased (antigen) levels or impaired function (activity) of protein S, leads to decreased degradation of factor Va and factor VIIIa and an increased propensity to venous thrombosis. Protein S circulates in human plasma in two forms: approximately 60% is bound to complement component C4b β-chain while the remaining 40% is free. Only free protein S has activated protein C cofactor activity.

Classification

There are three types of hereditary protein S deficiency:

  • Type I - decreased protein S activity: decreased total protein S (=both bound and free protein S) levels AND decreased free protein S levels (quantitative defect)
  • Type II - decreased protein S activity: normal free protein S levels AND normal total protein S levels (qualitative defect)
  • Type III - decreased protein S activity: decreased free protein S levels AND normal total protein S levels (quantitative defect)

Pathophysiology

Protein S deficiency can also be acquired due to vitamin K deficiency or treatment with warfarin, systemic sex hormone therapy and pregnancy, liver disease, and certain chronic infections (for example HIV). Vitamin K deficiency or treatment with warfarin generally also impairs the coagulation system itself (factors II, VII, IX and X), and therefore predisposes to bleeding rather than thrombosis. Protein S deficiency is the underlying cause of a small proportion of cases of disseminated intravascular coagulation (DIC), deep venous thrombosis (DVT) and pulmonary embolism (PE).

Genetics

Hereditary PSD is an autosomal dominant condition, resulting in a 50 percent chance of passing the disease to offspring. Less than half of those diagnosed with PSD will experience thrombosis, and those who do usually are affected only from the age of the late teens onwards.

Cost-Effectiveness of Therapy

A positive blood test can lead to the loss of health insurance benefits and/or employment, and the social downsides need to be balanced against the actual medical benefit of accurate diagnosis. Screening of young children is usually deferred because early testing is often inaccurate, and it is better to wait until they are old enough to decide for themselves whether they want to be tested.

References

Template:Hematology

Template:WikiDoc Sources